Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer
Clinical trial NCT02318901 · TERMINATED
Trial details
- NCT number
- NCT02318901
- Sponsor
- Western Regional Medical Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2018-08-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.